{
    "2019-09-06": [
        [
            {
                "time": "2018-09-01",
                "original_text": "Pfizer is a Top Drugmaker: Is it the Right Time to Buy It?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "drugmaker",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-02",
                "original_text": "FDA Grants Priority Review to Global Blood's SCD Candidate",
                "features": {
                    "keywords": [
                        "FDA",
                        "priority review",
                        "Global Blood",
                        "SCD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-03",
                "original_text": "Novartis' Capmatinib Gets Breakthrough Therapy Tag From FDA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Capmatinib",
                        "breakthrough therapy",
                        "FDA"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs",
                "features": {
                    "keywords": [
                        "AGN",
                        "opioid settlement",
                        "MRK",
                        "JNJ",
                        "EU approval"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-05",
                "original_text": "UPDATE 1-Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Pfizer",
                        "FDA",
                        "fast-track",
                        "lung cancer"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-06",
                "original_text": "4 Biotech Stocks With Big Catalysts in September",
                "features": {
                    "keywords": [
                        "biotech stocks",
                        "catalysts",
                        "September"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}